Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05887323 · ClinicalTrials.gov registry record
LBBAP Data Collection Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 221
- Enrollment target
NCT05887323 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 221 participants.
The verdict
NCT05887323 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 221 participants
- Enrollment target
Study Summary
The purpose of this registry is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients already implanted with the Tendril STS 2088 lead.
Interventions
- DEVICE Implantation of the Tendril 2088 lead in the LBBA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2023-04-25 |
| Est. Completion | 2023-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05887323
The ClinicalTrials.gov registry entry for NCT05887323 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of the Tendril 2088 lead in the LBBA is the first listed.
NCT05887323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05887323 about?
NCT05887323 is a clinical study titled "LBBAP Data Collection Registry". The purpose of this registry is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients already implanted with the Tendril STS 2088 lead.
What is the current status of trial NCT05887323?
This trial is currently completed. The enrollment target is 221 participants. The study started on 2023-04-25. Estimated completion is 2023-07-11.
What interventions are being tested in trial NCT05887323?
The interventions under investigation include: Implantation of the Tendril 2088 lead in the LBBA (DEVICE).
Who is sponsoring clinical trial NCT05887323?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.